✦ LIBER ✦
Similar response rates and superior early progression-free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous stem cell transplantation for recurrent or refractory Hodgkin lymphoma
✍ Scribed by John Kuruvilla; Tracy Nagy; Melania Pintilie; Richard Tsang; Armand Keating; Michael Crump
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 114 KB
- Volume
- 106
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.